In many cases, proteases are synthesized as inactive precursors to prevent undesirable protein degradation before arrival at their destinations. 1, 2) Proteases contain N-terminal extensions in the mature enzyme forms that function as cognate protease inhibitors by covering enzyme active sites.
2) The precursor is converted to an active mature form by release of the extension sequences, which are termed propeptides. The propeptides are usually removed either by autoprocessing following a drop in pH or by exogenous proteases. 3, 4) It has also been reported that propeptides function as intramolecular chaperones and that they play crucial roles in protein folding that guide mature domains to functional conformations. 5, 6) They are not part of the mature domain, as they are removed after the completion of protein folding, but they play important roles in the folding processes of functional proteins, because proteins cannot take proper conformations without propeptides. 7) A large number of propeptides from various proteases have been identified as intramolecular chaperones and inhibitors of mature enzymes, including subtilisin, 8) -lytic protease, 9) and carboxypeptidase Y. 10) Carboxypeptidase Y (CPY) is s vacuolar serine carboxypeptidase of the yeast Saccharomyces cerevisiae, and is produced as an inactive precursor (proCPY) with an N-terminal propeptide containing a signal peptide leading into vacuole. 10, 11) The propeptide of proCPY functions as an intramolecular chaperone, and assists the proper folding of mature CPY (mCPY).
10) It has been reported that the maturation of proCPY proceeds with cleavage of the propeptide by yeast vacuolar protease proteinase A and proteinase B.
12) The structure of proCPY has not yet been determined, and the molecular mechanism of the inhibition mediated by the propeptide remains unclear. mCPY is also inhibited by a carboxypeptidase Y inhibitor (I C ), and the crystal structure of mCPY-I C complex has been determined (Fig. 1A ).
13)
The crystal structure indicates that I C forms an equimolecular complex with mCPY through two binding sites: the N-terminal inhibitory reactive site (the primary CPY-binding site) and the secondary CPY-binding site. The N-terminal inhibitory reactive site of I C interacts with the substrate-binding site of mCPY (Fig. 1B) , and the secondary CPY-binding site interacts with the hydrophobic surface flanked by the mCPY active site. In particular, the N-terminal inhibitory reactive site is essential for CPY inhibition, because the N-terminal (Met1-Phe7) deleted mutant of I C does not form a complex with mCPY and has no inhibitory activity toward mCPY. 13 ) I C has a homologous protein, I C h, which has no CPY inhibitory activity. 14) This is because I C h lacks the N-terminal seven amino acids present in I C . This also indicates the important function of the N-terminal inhibitory reactive site, which is required for mCPY-I C interaction. In this study, amino acid sequence alignments between proCPY and I C were done to determine the inhibition mechanism of the propeptide, and the inhibition region was evaluated. The effect of the putative inhibitory region in the propeptide was analyzed by measuring the inhibitory activity of the peptide derived from the propeptide toward mCPY. Based on sequence alignment and activity measurement, we also discuss the propeptide-mediated inhibitory mechanism of mCPY. 
Materials and Methods
Preparation of mCPY. CPY was purchased from Oriental Yeast (Tokyo), and was further purified by ion exchange chromatography. The CPY solution was loaded onto a SOURCE 15Q 4.6/100 PE column (GE Healthcare, Buckinghamshire, UK) equilibrated with 0.01 M sodium phosphate buffer (pH 7.0). mCPY was eluted with equilibrated buffer containing 2 M NaCl, desalted with 0.1 M sodium phosphate buffer (pH 7.0), and concentrated by ultrafiltration.
Inhibitory activity of CPY in the presence of peptides. Peptides from the N-terminal region of I C and a propeptide similar to the N-terminus of I C (Table 1) were synthesized by Biologica (Nagoya, Japan) and used to measure CPY activity. The inhibitory activity of the peptides to mCPY was determined as the residual activity of mCPY with respect to the hydrolysis of the specific substrate of CPY, Suc-Ile-Ile-Trp-MCA, in 0.1 M sodium phosphate buffer (pH 7.0). Various peptides (final concentrations 20 mM) were mixed with 1 mL of mCPY (final concentration 1 mg/mL), and the mixtures were incubated at 30 C for 10 min. After incubation, various concentrations of Suc-Ile-Ile-Trp-MCA were applied to the samples, and fluorescence of the released 7-amino-4-methylcoumarin (AMC) was measured using Fluoroskan Ascent FL (Labsystems, Helsinki, Finland). The excitation and emission wavelengths were 355 nm and 460 nm respectively.
Results
Putative inhibitory region in the propeptide of proCPY based on sequence alignment proCPY is an inactive form of the enzyme due to the inhibitory function of its propeptide, but the inhibitory mechanism is currently unknown. It has also been reported that mCPY was specifically inhibited by I C , a proteinous proteinase inhibitor in the yeast S. cerevisiae. 13, 15) Hence, to explore the similarity in inhibitory functions between the propeptide of proCPY and I C , amino acid sequence alignment between proCPY and I C was done (Fig. 2A) . The alignment indicated that the sequences of the 13 amino acid residues at the Cterminus of the CPY propeptide and the 24 amino acid residues at the N-terminus of mCPY (K79-E115) were similar (about 34% similarity) to the sequences at the N-terminus of I C (M1-E39). Furthermore, the region of high sequence similarity contained the N-terminal inhibitory reactive site sequence of I C (double underline in Fig. 2B ) and part of the secondary CPY-binding site sequence of I C (broken underline in Fig. 2B ), which have been reported to be important for mCPY-I C interaction (Fig. 2B) . The N-terminal inhibitory reactive site, which is essential both for the inhibitory function toward mCPY and for the complex formation with mCPY, interacts with the S1 substrate binding site of mCPY, and the secondary CPY-binding site interacts with the hydrophobic surface flanked by the mCPY active site 13) (Fig. 1A) . This suggests that the C-terminal region of the propeptide, which is similar to the Nterminus of I C , interacts with the S1 site of mCPY and inhibits CPY activity in the form of proCPY.
C-Terminal region of the proCPY propeptide inhibited CPY activity
To determine whether the C-terminal region of the proCPY propeptide inhibits CPY activity, the inhibitory activities of the peptides described in Table 1 toward CPY were measured. A peptide identical to the Nterminus of I C (M1-Q9), which interacted with the substrate-binding site of CPY, was named ICN, and a peptide identical to the C-terminal sequence of the proCPY propeptide (K79-Q87), which was similar to the N-terminus of I C (M1-Q9), was named CPICN. The N-terminal peptide of I C h (ICHN), a homolog of I
C14)
that has no inhibitory activity toward CPY, 14) was used as negative control. Amino acid sequence alignments of CPICN, ICN, and ICHN are displayed in Fig. 1C . ICHN had no sequence identical to CPICN and ICN. All the V max values in the presence of the peptides shown in Table 1 were nearly identical to the values achieved in the absence of the peptides, whereas the K M values in the presence of the ICN and CPICN peptides were higher than the values obtained in the absence of the peptides and ICHN (Table 2 ). This indicates that the peptides function as competitive inhibitors. The inhibition constants (K i ) of ICN and ICHN for mCPY also indicated that ICN bound mCPY with a K i that was 5.7-fold higher than when ICHN was used as negative control.
14) ICN probably interacted with the substratebinding site of CPY and caused competitive inhibition. The K i of CPICN also decreased more than that of ICHN. These results indicate that the C-terminal region A B Fig. 1 . Structure of the mCPY-I C Complex. C . The alignments were done using the software programs CLUSTAL W 25) and ESPript. 26 ) Dots indicate gaps. Numbers represent the amino acid numbers for proCPY. Similar and identical residues are represented by black letters surrounded by squares and white letters on a black background respectively. A, Full-length amino acid sequence alignment of proCPY (I1-L512) and I C (M1-K219). The underlined sequences represent the similarity regions (proCPY, K79-E115; I C , M1-E39). The vertical lines (1st, 2nd, 3rd, and 4th) represent the cleavage sites of the propeptide.
12) The numbers next the lines indicate cleavage orders. The full-length amino acid sequence of I C h is also described. B, Sequence similarity regions of proCPY (K79-E115) and I C (M1-E39). Double underlining indicates the N-terminal inhibitory reactive site of I C , and the broken line indicates part of the secondary inhibitory reactive site of I C . C, Amino acid sequence alignment of proCPY (K79-Q87), the Nterminal region of I C (M1-Q9), and the N-terminal region of I C h (S2-N10). The peptides, which are identical to these sequences, were named CPICN, ICN, and ICHN respectively, as described in Table 1 . CPICN: C-terminal sequence of the propeptide (K79-Q87) of proCPY (Fig. 2) ; ICN, N-terminal region of I C (M1-Q9); ICHN, N-terminal region of I C h (S2-N10) All amino acids are described in single character codes.
of the proCPY propeptide is a potential inhibitor of CPY that interacts with the mCPY substrate-binding site.
Discussion
In some proteases, propeptides have been reported to function as inhibitors of the activity of the mature domains, in addition to their roles as intramolecular chaperones. 16, 17) In a study of serine protease subtilisins and their propeptides, the functions of subtilisin propeptides as intramolecular chaperons and inhibitors were identified, [18] [19] [20] and the structure of the subtilisinpropeptide complex was also determined. 20) Structural analysis indicated that the C-terminal strand of the propeptide binds to the subtilisin substrate-binding cleft. Although subtilisin does not have a specific endogenous inhibitor like I C in the case of CPY, heterologous protein Pleurotus ostreatus proteinase A inhibitor 1 (POIA1), which was isolated as a protease inhibitor 21) and showed amino acid sequence homology of approximately 30% to propeptides of subtilisin, can function as an intramolecular chaperone for foreign subtilisin in vitro and in vivo. 22) Moreover, when subtilisin was used as target protease, mutated POIA1, the six C-terminal residues of which had been replaced by those in the subtilisin propeptide, was converted into an inhibitor stronger than POIA1. 22) Protease inhibitors have also been reported to function as intramolecular chaperones. 23, 24) This indicates that any propeptide and any inhibitor have similarity, bind to mature enzymes, and relate to inhibition and folding in the same mechanism.
The structure of mCPY with its N-terminal propeptide (proCPY) is unclear. To investigate a possible inhibitory mechanism of mCPY through the action of the propeptide, we compared amino acid similarity between the Cterminus of the proCPY propeptide and the N-terminus of I C by sequence alignment. This is the first report to the effect that a proCPY propeptide and its endogenous inhibitor (I C ) show sequence similarity, unlike the subtilisin propeptide and its foreign inhibitors. As the N-terminus of I C bound directly to the substrate-binding site of mCPY and inhibited its activity, 13) the C-terminus of the propeptide, which is similar to the partial sequence of I C , might also bind to the substrate-binding site and keep the CPY in inactive form. It has been reported that the maturation of CPY is processed by four-step digestion of the propeptide (Fig. 2A) , and that CPY has complete activity after the third cleavage of the propeptide. 12) That is, the region between the third cleavage site and the fourth is the area involved in the inhibition of CPY activity. This agrees with our result of sequence alignment, since the region between the third and fourth cleavage sites included the inhibitory sequences predicted from the sequence alignment determined in this study. In fact, the peptide that was identical to the C-terminal sequence of the proCPY propeptide functioned as competitive inhibitors of mCPY, as observed in the peptide that was identical to the N-terminal sequence of I C (Table 2 ). I C15) and I C h 14) are members of the PEBP (phosphatidylethanolamine-binding protein) family, as classified by amino acid sequence alignment. PEBPs can be grouped into two types, short and long groups. I C belongs to the long group and I C h belongs to the short group. 14) As compared to long PEBPs, short PEBPs lack 6-11 N-terminal amino acids. 14) Since the seven Nterminal amino acids of I C are essential for inhibitory activity toward mCPY, I
C h, which lacks the corresponding seven N-terminal amino acids, must have noninhibitory activity toward mCPY. 14) Thus, peptide ICHN, which is identical to the N-terminus of I C h, had a weak inhibitory effect on mCPY (Table 2) , although a competitive effect was observed.
In this study, a similarity between the proCPY propeptide and an endogenous specific inhibitor of mCPY, I
C , was recognized for the first time, and we suggest a mechanism of mCPY inhibition by the propeptide. This should lead to an overall understanding of the CPY maturation mechanism (conversion of proCPY to mCPY) assisted by the propeptide.
